doi: 10.1159/000183924.
Epub 2008 Dec 17.
Downmodulatory effects of the antihistaminic drug bepotastine on cytokine/chemokine production and CD54 expression in human keratinocytes
Affiliations
- PMID: 19088500
- DOI: 10.1159/000183924
Item in Clipboard
Downmodulatory effects of the antihistaminic drug bepotastine on cytokine/chemokine production and CD54 expression in human keratinocytes
Skin Pharmacol Physiol.
2009.
Abstract
Bepotastine besilate is an antihistaminic drug of the second generation with superior clinical responses. In this study, we investigated whether bepotastine modulates the production of cytokines/chemokines and the expression of CD54 in human epidermal keratinocytes. The production of IL-1alpha, CXCL10, and CCL17 and the expression of CD54 were significantly suppressed by the addition of bepotastine. Bepotastine exerts its antiallergic action on keratinocytes by suppressing the production of certain proinflammatory cytokines, both Th1 and Th2 chemokines, and possibly by inhibiting the expression of CD54.
Copyright 2008 S. Karger AG, Basel.
Similar articles
-
Downmodulatory effects of cetirizine and levocetirizine on cytokine/chemokine production and CD54 expression in keratinocytes.J Dermatol. 2011 Jul;38(7):717-9. doi: 10.1111/j.1346-8138.2010.01061.x. Epub 2010 Nov 2. J Dermatol. 2011. PMID: 21352306 No abstract available.
-
Inhibition of T helper 2 chemokine production by narrowband ultraviolet B in cultured keratinocytes.Br J Dermatol. 2007 May;156(5):830-7. doi: 10.1111/j.1365-2133.2007.07774.x. Epub 2007 Feb 20. Br J Dermatol. 2007. PMID: 17313491
-
Antihistaminic drug olopatadine downmodulates CCL17/TARC production by keratinocytes and Langerhans cells.J Dermatol. 2009 Dec;36(12):654-7. doi: 10.1111/j.1346-8138.2009.00726.x. J Dermatol. 2009. PMID: 19958451 No abstract available.
-
Epidermal chemokines and modulation by antihistamines, antibiotics and antifungals.Exp Dermatol. 2008 Feb;17(2):81-90. doi: 10.1111/j.1600-0625.2007.00657.x. Epub 2007 Nov 22. Exp Dermatol. 2008. PMID: 18034836 Review.
-
Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate.Curr Med Res Opin. 2010 Oct;26(10):2329-38. doi: 10.1185/03007995.2010.486753. Curr Med Res Opin. 2010. PMID: 20735291 Review.
Cited by
-
Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis.Clin Ophthalmol. 2011;5:201-7. doi: 10.2147/OPTH.S8665. Epub 2011 Feb 15. Clin Ophthalmol. 2011. PMID: 21386912 Free PMC article.
-
An Investigator-Blind Randomized Controlled Trial Comparing Effectiveness, Safety of Levocetirizine and Bepotastine in Chronic Urticaria.Indian J Dermatol. 2021 Sep-Oct;66(5):472-478. doi: 10.4103/ijd.ijd_813_20. Indian J Dermatol. 2021. PMID: 35068500 Free PMC article.
-
Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function.J Invest Dermatol. 2013 Feb;133(2):469-78. doi: 10.1038/jid.2012.335. Epub 2012 Sep 27. J Invest Dermatol. 2013. PMID: 23014339 Free PMC article.
-
Oral bepotastine: in allergic disorders.Drugs. 2010 Aug 20;70(12):1579-91. doi: 10.2165/11205880-000000000-00000. Drugs. 2010. PMID: 20687621 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
